文献速递消化系统肿瘤

胰腺癌中癌相关成纤维细胞的功能异质性及其由IL6介导的不同治疗耐药作用

Identification of Functional Heterogeneity of Carcinoma-Associated Fibroblasts with Distinct IL6-Mediated Therapy Resistance in Pancreatic Cancer.
PubMed 文献 · Cancer Discov · 2022-01-01

该研究利用单细胞RNA测序、多重免疫染色及多种遗传小鼠模型,在胰腺导管腺癌(PDAC)中鉴定出功能相反的癌相关成纤维细胞(CAF)亚群:清除FAP+ CAF提高生存,而清除αSMA+ CAF降低生存。在双重组酶遗传PDAC模型中,仅αSMA+ CAF缺失IL6可改善吉西他滨疗效,并与抗PD-1免疫治疗协同显著改善小鼠生存。

要点

  • PDAC中存在功能相反的CAF亚群:FAP+ CAF促瘤,αSMA+ CAF抑瘤。
  • 清除FAP+ CAF提高生存,清除αSMA+ CAF降低生存。
  • αSMA+ CAF缺失IL6改善吉西他滨疗效,并与抗PD-1协同延长生存。

核心结论

  • PDAC中CAF存在功能异质性,促瘤性FAP+ CAF与抑瘤性αSMA+ CAF在肿瘤进展和治疗反应中作用不同。

研究设计与样本

  • 研究采用单细胞RNA测序、多重免疫染色及多种遗传小鼠模型,并使用双重组酶遗传PDAC模型。

主要发现

  • 清除FAP+ CAF导致生存期增加,而清除αSMA+ CAF导致生存期降低。
  • 促瘤性FAP+ CAF(TP-CAF)与抑瘤性αSMA+ CAF(TR-CAF)差异调节癌症相关通路及调节性T细胞积聚。
  • 在双重组酶遗传PDAC模型中,仅从αSMA+ CAF而非FAP+ CAF缺失IL6时,可观察到吉西他滨疗效改善。
  • 因αSMA+ CAF缺乏IL6所致的吉西他滨疗效改善,与抗PD-1免疫治疗协同,显著改善PDAC小鼠生存。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: The tumor microenvironment in pancreatic ductal adenocarcinoma (PDAC) involves a significant accumulation of fibroblasts as part of the host response to cancer. Using single-cell RNA sequencing, multiplex immunostaining, and several genetic mouse models, we identify carcinoma-associated fibroblasts (CAF) with opposing functions in PDAC progression. Depletion of fibroblast activation protein (FAP)+ CAFs results in increased survival, in contrast to depletion of alpha smooth muscle actin (αSMA)+ CAFs, which leads to decreased survival. Tumor-promoting FAP+ CAFs (TP-CAF) and tumor-restraining αSMA+ CAFs (TR-CAF) differentially regulate cancer-associated pathways and accumulation of regulatory T cells. Improved efficacy of gemcitabine is observed when IL6 is deleted from αSMA+ CAFs but not from FAP+ CAFs using dual-recombinase genetic PDAC models. Improved gemcitabine efficacy due to lack of IL6 synergizes with anti-PD-1 immunotherapy to significantly improve survival of PDAC mice. Our study identifies functional heterogeneity of CAFs in PDAC progression and their different roles in therapy response. SIGNIFICANCE: PDAC is associated with accumulation of dense stroma consisting of fibroblasts and extracellular matrix that regulate tumor progression. Here, we identify two distinct populations of fibroblasts with opposing roles in the progression and immune landscape of PDAC. Our findings demonstrate that fibroblasts are functionally diverse with therapeutic implications. This article is highlighted in the In This Issue feature, p. 1397.

来源:Cancer Discov,查看原文。版权归原作者所有。

引用

  1. McAndrews KM, Chen Y, Darpolor JK, et al. Identification of Functional Heterogeneity of Carcinoma-Associated Fibroblasts with Distinct IL6-Mediated Therapy Resistance in Pancreatic Cancer. Cancer Discov. 2022. PMID: 35348629. doi:10.1158/2159-8290.CD-20-1484

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。